Parabolic Drugs Share Price

Parabolic Drugs

CMP as on 25-Jan-21 13:00

₹ 5.50
-0.25 -4.35%

Open

₹ 5.50

Turnover (lac)

Prev. Close

₹ 5.75

Day's Vol (shares)

₹ 123

Day's Range (₹)

₹ 5.50
₹ 5.50

CMP as on25-Jan-21 11:07

₹ 5.70
-0.29 -4.84%

Open

₹ 5.70

Turnover (lac)

Prev. Close

₹ 5.99

Day's Vol (shares)

₹ 21

Day's Range

₹ 5.70
₹ 5.70

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 05-Feb-2021 - -
Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve Un-Audited Financial Results for the Quarter and Nine months ended on 31st December, 2020 . Pursuant to the letter addressed to your good office on 19th January, 2021 and 22nd January, 2021, whereby, your good self was intimated regarding the approval of resolution plan by Honble National Company Law Tribunal, Chandigarh Bench and as per approved plan Company shall stand delisted from the Stock Exchanges from date of passing order and as per letter dated 25.01.2021 intimated to Stock Exchange, Company had decided to set Friday, 29th January, 2021 as the Record Date for suspension of the Trading of all the Units/scrips from the Stock Exchange; further, Stock Exchange had decided to set 28th January, 2021 as effective date for suspension of trading of Units/Scrips. Pursuant to Intimation Letter dated 05.02.2021 and Regulation 30 & 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015; we furnish herewith the revised Un-audited Financial Results for the Quarter and Nine Months ended on 31st December, 2020. We hereby enclosed the Un-audited financial results for the Quarter and Nine Months ended 31.12.2020 along with the Limited Review Report for the said period. The Meeting was commenced from 05:00 pm and concluded at 06:15 pm This is for your information and records. (As Per BSE Announcement Dated on 11/02/2021)
Board Meeting - 30-Nov-2020 - -
Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/12/2020 ,inter alia, to consider and approve revised Un-Audited Financial Results for the Quarter and half year ended on 30th September, 2020 be considered and disseminated on Monday, 07th December, 2020. Pursuant to the Companys Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for Designated Persons from Tuesday, December 31, 2020 and the same shall remain closed till 48 hours after announcement of revised Financial Results for the quarter and half year ended September 30, 2020 to the stock exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. You are requested to display the same on the Notice Board of your Exchange for the information of members and general public. Pursuant to Intimation Letter dated 30.11.2020and Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015; we furnish herewith the revised Un-audited Financial Results for the Quarter and half year ended on 30th September, 2020. The Meeting was commenced from 05:00 pm and concluded at 06:15 pm This is for your information and records. (As per BSE Announcement Dated on 7/12/2020)
Board Meeting - 06-Nov-2020 - -
Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve Pursuant to the Regulation 29 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Un-audited Financial Results for the Quarter and half year ended on 30th September, 2020 be considered and disseminated on Thursday, 12th November, 2020. Pursuant to letter dated 25th September, 2020; It is further informed that in terms of the provisions of Prohibition of Insider Trading Regulations, 2015; issued by Securities Exchange Board of India (SEBI) and Companys code of conduct for prevention of Insider Trading the trading window for dealing in the securities of the Company shall remain closed from Saturday, September 26, 2020 and the same shall remain closed till 48 hours after announcement of Financial Results for the quarter and half year ended September 30, 2020 to the stock exchanges. This information is for your record and information. Quarterly Results (Revised) (As per BSE Bulletin Dated on 12/11/2020) Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020 ,inter alia, to consider and approve Quarter and half year ended on 30th September, 2020 Pursuant to letter dated 06th November, 2020, where the Company had intimated to the Stock Exchange that Un-audited Financial Results for the Quarter and half year ended on 30th September, 2020 be considered and disseminated on Thursday, 12th November, 2020, but now it hereby decided that due to non-availability Resolution Professional (RP), we are unable to disseminate the same on 12th November, 2020 and rather than the Un-audited Financial Results for the Quarter and half year ended on 30th September, 2020 will consider and disseminate on Friday, the 13th November, 2020. You are requested to display the same on the Notice Board of your Exchange for the information of members and general public. (AS Per BSE Announcement Dated on 12.11.2020) Pursuant to Intimation Letter dated 13.11.2020 and 06.11.2020 and Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we furnish herewith the Un-audited Financial Results for the Quarter and half year ended on 30 September, 2020. The Meeting was commenced from 05:00 pm and concluded at 06:15 pm This is for your information and records. (As per BSE Announcement Dated on 13/11/2020)
Board Meeting - 18-Aug-2020 - -
Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2020 ,inter alia, to consider and approve updated Audited Financial Results for the quarter and financial year ended 31.03.2019. The Stock Exchange is aware that Parabolic Drugs Limited is under Corporate Insolvency Resolution Process and in terms of the order of the Honble NCLT dated August 30, 2018, the powers of the Board of Directors are suspended and are vested in the Resolution Professional, business and assets are being managed by the Resolution Professional. The Resolution Professional is performing the functions as mentioned under Insolvency and Bankruptcy Code (the Code). In view of the above and pursuant to Regulation 29 of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that updated Audited Financial Results for the quarter and financial year ended 31.03.2019 will be considered and disseminated on 24th August, 2020. This is for information and records. Pursuant to Intimation Letter dated 18.08.2020 and Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we furnish herewith the updated Audited Financial Results of the Company for the Quarter and Year ended 31.03.2019. The Meeting was commenced from 11:00 am and concluded at 12:15 pm This is for your information and records. (AS Per BSE Announcement Dated on 24.08.2020)
Open ZERO Brokerage Demat Account